Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03344536
Title A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Debio 1347 + Fulvestrant

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST